Please log in to determine if you are eligible to purchase PT Programs.
HUMAN PAPILLOMAVIRUS, SUREPATH - CHPVK
CHPVK
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Analyte/Procedure
Challenges per Shipment
Number of Shipments
HPV
5
Three shipments per year
High-risk HPV genotyping (optional)
5
Additional Information
Each laboratory should choose the program that best reflects the transport media received in its facility. If your laboratory receives two types of media, order the programs that are appropriate for your specific laboratory (CHPVD, CHPVM, or CHPVK).
For laboratories that perform HPV genotyping using ThinPrep PreservCyt or SurePath Preservative Fluid transport mediums on site, programs CHPVM, CHPVK, and select CHPVJ specimens provide an opportunity to report specific HPV genotypes.
The CAP does not report genotyping responses to the CMS.
Program Information
Five simulated cervical specimens
SurePath Preservative Fluid transport medium and corresponding vial of diluent